J. Scott Bertram

Mr. Bertram represents plaintiffs in catastrophic injury and death cases involving pharmaceutical products liability, medical negligence, nursing home negligence, and other personal injuries. Since 1997, he has been involved in drug product liability mass torts litigation, including Fen-Phen, Rezulin, Propulsid, Baycol, and Vioxx.

Mr. Bertram represented clients in the following multi-district litigations:

In Re Diet Drug (phentermine/fenfluramine/dexfenfluramine) Products Liability Litigation, MDL #1203;

In Re Propulsid Products Liability Litigation, MDL #1355;

In Re Baycol Products Liability Litigation, MDL #1431;

In Re Rezulin Products Liability Litigation, MDL #1348;

In Re Vioxx Product Liability Litigation, MDL #1657;

In Re Bextra and Celebrex Marketing Sales Practices and Product Liability Litigation, MDL #1699;

In Re Avandia Product Liability Litigation, MDL #­1871; and

Served on the Steering Committee in In Re:  Oral Sodium Phosphate Solution-Based Products Liability Litigation, in the United States District Court, Northern District of Ohio,  Case No. 1:09-SP-80000 (MDL Docket No. 2066).

Mr. Bertram is currently representing over 120 Plaintiffs who claim they have developed the movement disorder tardive dyskinesia as a result of taking the heartburn drug Reglan. Those cases are now pending in consolidated state court actions in Pennsylvania, New Jersey, California and Missouri.